Work

External validation of new prostate cancer risk groups by PSMA-PET (PPP3).

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.5112

Authors: Wolfgang Peter Fendler, Madeleine Josefine Karpinski, Caner Civan, Sebastian Hoberück, Alexis Vrachimis, Weijing Tao, Michael Sathekge, Francesco Mattana, Dilsat Firat Arslan, Ali Kibar, Weijun Wei, Ken Herrmann, Boris A. Hadaschik, Kambiz Rahbar, Tobias Maurer

Institutions: Essen University Hospital, University of Duisburg-Essen, Deutsches Konsortium für Translationale Krebsforschung, University Hospital Carl Gustav Carus, Technische Universität Dresden, Huaian First People’s Hospital, Nanjing Medical University, Steve Biko Hospital, University of Pretoria, European Institute of Oncology, Istanbul University, Trakya University, Shanghai Jiao Tong University, Renji Hospital, University Hospital Münster, University Medical Center Hamburg-Eppendorf, Martini-Klinik

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Prostate Cancer Foundation, Deutsche Forschungsgemeinschaft

Award: G1216105734

OpenAlex ID: W7162490983

Cites:

Cited by:

Related to: